Taiwan FDA registration e2cae031db66436c493b7652e5233463

Nanobia fibrinogen protein decomposition assay reagent

TW: 納諾比亞纖維蛋白原蛋白分解物測定試劑
Taiwan flagTaiwan·Risk Class 2·SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT·Registered May 20, 2013 – May 20, 2018Cancelled
Registration details
Analysis ID
e2cae031db66436c493b7652e5233463
Customs Code
DHA00602469004
Company information
Manufacturer Country
Japan
Authorized Representative
KUO'S YUAN IN ENTERPRISE CO., LTD.
Product details
Intended Use
Detect fibrous protein degradants (FDPs) in blood or serum.
Product Type (Level 1)
B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1660 Quality control materials (analytical and non-analytical); A.1150 calibration;; B.7320 Analysis of pro-fiber/fiber-based protein disintegration products
Import Information
import
Dates and status
Registration Date
May 20, 2013
Expiry Date
May 20, 2018
Cancellation Date
Nov 04, 2019
Cancellation information
Status
Logged out
Reason
未展延而逾期者
About this record

Access comprehensive regulatory information for Nanobia fibrinogen protein decomposition assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e2cae031db66436c493b7652e5233463 and manufactured by SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT. The authorized representative in Taiwan is KUO'S YUAN IN ENTERPRISE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices